" /> FOLFOX-Bevacizumab Regimen - CISMeF





Preferred Label : FOLFOX-Bevacizumab Regimen;

NCIt synonyms : FOLFOX Plus Bevacizumab; FOLFOX/Avastin Regimen; FOLFOX-Avastin Regimen; Folinic Acid/Fluorouracil/Oxaliplatin/Bevacizumab Regimen; FOLFOX/Bevacizumab Regimen; FOLFOX Plus Avastin; Leucovorin/Fluorouracil/Oxaliplatin/Bevacizumab; Folfox Bevacizumab Regimen; Folfox Bevacizumab;

NCIt related terms : FOLFOX4 and Bevacizumab-bvzr; FOLFOX4 and Bevacizumab-aybi; FOLFOX4 and Bevacizumab-equi; FOLFOX4 and Bevacizumab-awwb; FOLFOX4 and Bevacizumab-adcd; FOLFOX4 and Bevacizumab; FOLFOX4 and Bevacizumab-maly; FOLFOX4 and Bevacizumab-onbe; FOLFOX4 and Bevacizumab-tnjn;

NCIt definition : A regimen consisting of leucovorin, fluorouracil and oxaliplatin (FOLFOX), plus bevacizumab that is used for the treatment of colon cancer and mucinous neoplasms of the ovary.;

NCI Metathesaurus CUI : CL523559;

Codes from synonyms : 127400; 127622; 127326; 14776; 127548; 127252; 127474; 127178; 142409;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.